Csl (QX) 주식 가격. CSLLY - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

86.16

매수가

85.13

매도가

87.03

거래량

75,267

85.63 일간 변동폭 86.48

83.31 52주 범위 109.00

market_cap

83.274B

전일 종가

85.8335

개장가

85.9555

최근 거래 시간

172

86.085

(average)

마지막 거래 시간

재정 규모

US$ 6,485,145

VWAP

86.1619

평균 볼륨(3m)

79,350

발행 주식

966,505,458

배당수익률

주가수익률

100.61

주당순이익(EPS)

2.73

매출

14.69B

순이익

2.64B

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology.

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.csl.com.au

본부

Melbourne, Victoria, Aus

설립됨

1916

Csl Ltd (QX) is listed in the Biological Pds,ex Diagnstics sector of the OTC 시장 with ticker CSLLY. The last closing price for Csl (QX) was US$85.83. Over the last year, Csl (QX) shares have traded in a share price range of US$ 83.31 to US$ 109.00.

Csl (QX) currently has 966,505,458 shares in issue. The market capitalisation of Csl (QX) is US$82.96 billion. Csl (QX) has a price to earnings ratio (PE ratio) of 100.61.

Form 3 - Initial statement of beneficial ownership of securities

CSL Behring Announces the 2015 Interlaken Leadership Awards Recipient

CSL Behring Announces the 2015 Interlaken Leadership Awards Recipient Awards Program Supports Novel Research of Immunoglobulin Therapy for Neurological Disorders PR Newswire KING OF PRUSSIA, Pa...

CSL Behring Presents rIX-FP for Hemophilia B Phase III Data Evaluating Efficacy, Safety and Improved Dosing at ISTH 2015

CSL Behring Presents rIX-FP for Hemophilia B Phase III Data Evaluating Efficacy, Safety and Improved Dosing at ISTH 2015 PR Newswire TORONTO, June 24, 2015 - Data supports prolonged dosing...

CSL Behring Announces Pivotal Data of Novel rVIII-SingleChain Therapy in Adolescents and Adults with Hemophilia A

CSL Behring Announces Pivotal Data of Novel rVIII-SingleChain Therapy in Adolescents and Adults with Hemophilia A PR Newswire TORONTO, June 24, 2015 Data Presented during Late Breaking Session at...

Defining And Differentiating The Value Of Therapies Used To Treat Rare Disease Patients Is A Challenge For Payers

Defining And Differentiating The Value Of Therapies Used To Treat Rare Disease Patients Is A Challenge For Payers Panel of experts examines how value of biopharmaceutical technologies is assessed...

CSL Behring to Present Pivotal Data for rVIII-SingleChain and rIX-FP at 2015 ISTH Congress

CSL Behring to Present Pivotal Data for rVIII-SingleChain and rIX-FP at 2015 ISTH Congress PR Newswire KING OF PRUSSIA, Pa., June 16, 2015 More than 20 abstracts focusing on investigational and...

Important New Findings Published in The Lancet Support the Use of Zemaira® [Alpha1-Proteinase Inhibitor (Human)] in Patients...

Important New Findings Published in The Lancet Support the Use of Zemaira® [Alpha1-Proteinase Inhibitor (Human)] in Patients with Alpha-1 Antitrypsin Deficiency (AATD) PR Newswire KING OF...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-1.74	-1.9795221843	87.9	90.01	84.81	122442	86.89287231	DR
4	2.85	3.4209578682	83.31	90.04	83.31	84367	87.59236848	DR
12	-11.5	-11.775547819	97.66	99.549	83.31	79350	89.28672697	DR
26	-14.08	-14.0462889066	100.24	109	83.31	46034	92.09812325	DR
52	-6.89	-7.40462117141	93.05	109	83.31	39884	92.79984586	DR
156	-13.18	-13.2675659352	99.34	110.25	71.51	66106	91.63071191	DR
260	-17.805	-17.1259558505	103.965	117.98	71.51	58546	95.67080892	DR

CSLLY - Frequently Asked Questions (FAQ)

What is the current Csl (QX) share price?

The current share price of Csl (QX) is US$ 86.16

How many Csl (QX) shares are in issue?

Csl (QX) has 966,505,458 shares in issue

What is the market cap of Csl (QX)?

The market capitalisation of Csl (QX) is USD 82.96B

What is the 1 year trading range for Csl (QX) share price?

Csl (QX) has traded in the range of US$ 83.31 to US$ 109.00 during the past year

What is the PE ratio of Csl (QX)?

The price to earnings ratio of Csl (QX) is 100.61

What is the cash to sales ratio of Csl (QX)?

The cash to sales ratio of Csl (QX) is 18.09

What is the reporting currency for Csl (QX)?

Csl (QX) reports financial results in USD

What is the latest annual turnover for Csl (QX)?

The latest annual turnover of Csl (QX) is USD 14.69B

What is the latest annual profit for Csl (QX)?

The latest annual profit of Csl (QX) is USD 2.64B

What is the registered address of Csl (QX)?

The registered address for Csl (QX) is 45 POPLAR ROAD, PARKVILLE, MELBOURNE, VICTORIA, 3052

What is the Csl (QX) website address?

The website address for Csl (QX) is www.csl.com.au

Which industry sector does Csl (QX) operate in?

Csl (QX) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
TMGIMarquie Group Inc (PK)	US$ 0.0002 (19,900.00%)	4.03M
SEANSAEAN Group Inc (PK)	US$ 1.87 (18,600.00%)	100
ZPASZoompass Holdings Inc (CE)	US$ 0.0001 (9,900.00%)	675
GMPRGourmet Provisions International Corporation (PK)	US$ 0.0001 (9,900.00%)	35.31M
PLPLPlandai Biotechnology Inc (PK)	US$ 0.0001 (9,900.00%)	18.06M
STNXStartronix International Inc (CE)	US$ 0.000001 (-99.99%)	450
AWINAERWINS Technologies Inc (CE)	US$ 0.000001 (-99.97%)	2.03k
ISOLImage Software Inc (CE)	US$ 0.000001 (-99.91%)	59.2k
NBIONascent Biotech Inc (CE)	US$ 0.0002 (-99.55%)	8.7k
FHBCFernhill Beverage Inc (CE)	US$ 0.000001 (-99.24%)	10k
GTCHGBT Technologies Inc (PK)	US$ 0.0001 (0.00%)	349.77M
VTXBVortex Brands Company (PK)	US$ 0.0002 (0.00%)	297.52M
EMEDElectroMedical Technologies Inc (PK)	US$ 0.0002 (0.00%)	233.53M
PHILPHI Group Inc (PK)	US$ 0.0002 (-33.33%)	184.12M
HMBLHUMBL Inc (PK)	US$ 0.0009 (-5.26%)	179.2M